Spain has not simply given every woman a new pot of paid menopause days. What it has done is more specific — and, in some ways, more significant.

From 1 December 2026, Spain is due to give women whose medically recognised menopause-related condition makes them temporarily unable to work access to a specially protected form of sickness absence. So while headlines describing Spain menopause leave are understandable, “paid menopause sick leave” is a more accurate description of what is changing.

For women in the UK, the change is worth watching. It marks an unusual attempt to recognise severe menopause-related ill health explicitly within a national social-security system — at the same time as UK employers face growing legal and policy expectations to support staff experiencing menopause.

Key takeaways

• Spain’s reform covers a medically coded, limiting menopause-related disorder that prevents a woman from working. Simply being perimenopausal or menopausal does not automatically qualify.

• It is technically a special form of temporary incapacity, rather than a new statutory entitlement to ordinary paid leave.

• The employer pays full salary for the first day; from the following day, the relevant Social Security body pays sickness benefit. The benefit follows the ordinary common-contingency rate: generally 60% of the regulatory base up to day 20 and 75% from day 21.

• Unlike ordinary sickness absence for common illness, this special category has no minimum previous contribution period.

• The relevant provisions are scheduled to take effect on 1 December 2026. As at 4 November 2026, however, Real Decreto-ley 31/2026 still requires validation by Spain’s parliamentary Permanent Deputation, because the Cortes were dissolved for the 29 November general election.

What exactly is Spain changing?

On 20 October 2026, the Spanish government approved Real Decreto-ley 31/2026, published in the official state gazette, the Boletín Oficial del Estado (BOE), on 21 October. Among a wider package of social-security reforms, it added a new special category of temporary incapacity for a woman with a “limiting pathology due to a secondary menopausal disorder”, provided that the condition is appropriately coded, she is receiving public-healthcare treatment and it prevents her from working.

That wording matters.

The legislation does not say that menopause itself is an illness, nor does it grant time off simply because someone has hot flushes, disturbed sleep or brain fog. Eligibility depends on a clinician determining that a qualifying condition is sufficiently limiting to make the woman temporarily unable to work.

The medical practitioner within Spain’s public health service is responsible for identifying special temporary-incapacity cases using the appropriate coding. The decree itself does not publish a reader-friendly list of menopause symptoms or severity thresholds that automatically qualify, so reports claiming that particular symptoms guarantee leave go beyond what the legislation currently says.

This is one of the most important points for accurate reporting: the law creates a route for medically certified incapacity caused by a menopause-related disorder; it does not create a blanket “menopause day” entitlement.

Is Spain’s menopause leave fully paid?

Not necessarily.

On the first day of absence, the employer is responsible for the woman’s full salary. From the following day, the sickness benefit is paid by the relevant Social Security managing or collaborating body.

The new menopause category receives the same level of benefit as temporary incapacity caused by ordinary common contingencies. Spain’s Social Security guidance states that this is normally 60% of the regulatory base through day 20 and 75% from day 21 onwards.

That makes “paid menopause leave” a slightly misleading phrase if readers interpret “paid” as meaning normal salary continues in full. Individual collective agreements or employment arrangements could potentially provide more generous terms, but the statutory mechanism itself is a Social Security sickness benefit.

There is another important difference from ordinary sickness absence. For standard common illness, Spanish law normally requires at least 180 days of contributions during the previous five years before someone qualifies for the benefit. The new menopause-related special-incapacity category specifically removes that minimum contribution requirement.

The legislation also extends the special-incapacity framework across several parts of Spain’s social-security system, including provisions covering certain public-sector mutual schemes and workers in the maritime sector.

Why has menopause become a workplace issue?

For some women, menopause symptoms are mild. For others, they can substantially affect daily life and work.

NICE says menopause-associated symptoms vary from minor to severe and can include vasomotor symptoms such as hot flushes and sweats, mood effects, genitourinary symptoms and musculoskeletal symptoms. NHS guidance also lists disrupted sleep, anxiety, memory problems and difficulty concentrating, and notes that symptoms can affect work as well as relationships and everyday life.

Recent research supports taking the workplace impact seriously while avoiding the assumption that menopause automatically reduces women’s ability to work.

A systematic review published after searches through July 2024 included 29 observational studies. It found moderate-to-high-quality evidence that overall menopause symptoms, psychological symptoms, vasomotor symptoms and poorer sleep were associated with lower productivity while at work; vasomotor symptoms were also associated with absenteeism. 

Evidence for many other work and lifestyle factors remained limited or inconclusive.

Another systematic review, searching evidence to November 2024, reached a more cautious conclusion. Menopausal status itself was not consistently associated with poorer work ability, and although symptom severity may affect work outcomes, findings were mixed and many studies had important risks of bias or confounding.

That distinction is crucial. Being menopausal does not make a woman less capable of working. Severe symptoms can, however, make work considerably harder for some women.

Spanish data offer useful context. A 2025 EADA Business School survey of 575 employed women aged 45–58 found that 93.5% reported at least one menopause-related symptom and 60.4% reported seven or more. Fatigue, sleep problems and muscular discomfort were among the most commonly reported. Yet 82% said they had never taken time off because of symptoms, while more than half had considered leaving their job. Because this was a survey rather than a population-level clinical study, the figures should not be treated as prevalence estimates for all Spanish women.

The same survey found that only 5% of respondents said their organisation offered specific menopause support, while flexible hours, information and remote working were among the measures women valued.

Evidence on workplace interventions is still developing. A 2023 systematic review found just five eligible intervention studies — two randomised trials and three uncontrolled studies — involving 293 women and 61 managers or supervisors. That is enough to justify further investigation, but not enough to claim that any single workplace menopause programme has been proven universally effective.

Myth vs fact: what Spain’s new law does — and does not — mean

Myth: “Every woman in Spain can now take paid menopause leave.”
Fact: The legislation is limited to women with a medically recognised and appropriately coded menopause-related condition that prevents them from working while they are receiving public healthcare.

Myth: “Spain has classified menopause as a disease.”
Fact: The law does not say that menopause itself is an illness. It creates special temporary-incapacity protection when a qualifying menopause-related pathology is sufficiently limiting to prevent work.

Myth: “Women receive their normal salary throughout menopause leave.”
Fact: The employer covers full salary on day one. The Social Security benefit then applies from day two and is generally calculated at 60% of the regulatory base until day 20 and 75% thereafter.

Myth: “The scheme is already operating.”
Fact: The decree entered into force on 21 October, but the provisions governing this special incapacity are scheduled to have effect from 1 December 2026. As at 4 November, parliamentary validation remained outstanding.

What does this mean for women in the UK?

The UK does not currently have a separate statutory menopause-leave entitlement equivalent to Spain’s new special category. Instead, menopause at work sits within existing sickness, equality, health-and-safety and employment frameworks.

Menopause is not itself a protected characteristic under the Equality Act 2010. However, Acas and the Equality and Human Rights Commission explain that menopause-related treatment can engage protections relating to sex, age or disability. If symptoms have a substantial and long-term adverse effect on normal day-to-day activities and meet the legal definition of disability, an employer can have a duty to make reasonable adjustments.

UK policy is also moving towards more explicit menopause support. Since April 2026, employers with at least 250 employees have been able to publish voluntary action plans addressing their gender pay gap and support for employees experiencing menopause. 

Government implementation plans say these are intended to become mandatory for relevant public authorities in March 2027 and for private and voluntary-sector employers in April 2027, subject to the required legislation and implementation process.

For an individual woman struggling at work now, practical steps can include keeping a brief record of symptoms and how they affect particular tasks, speaking to a GP if symptoms are difficult to manage, and discussing appropriate workplace changes with a manager, HR or occupational health. Depending on the role, adjustments might include temperature control, easier access to drinking water or toilets, flexibility around start times, temporary changes to duties or greater opportunity for home working. Acas, NHS England and the British Menopause Society all emphasise individualised workplace support rather than a one-size-fits-all approach.

A relatable example is a woman whose night sweats are repeatedly disrupting sleep and who then struggles with concentration during early-morning meetings. She may not need — or want — extended sickness absence. A later start, hybrid working or a temporary adjustment to meeting patterns could be enough. Another woman experiencing much more severe symptoms may genuinely be unable to work for a period. The point of good menopause policy is to make room for both experiences rather than treating menopause as automatically disabling or automatically trivial.

Frequently asked questions

Does Spain have paid menopause leave?

Spain has created a special form of temporary-incapacity protection for medically coded menopause-related conditions that prevent a woman from working. It is more accurately described as menopause-related sick leave than a general paid-leave entitlement. The relevant provisions are scheduled to apply from 1 December 2026.

Who can qualify for Spain’s menopause sick leave?

The law applies where a woman has a limiting pathology associated with a coded secondary menopausal disorder, is receiving care from Spain’s public health service and is unable to work because of that condition. Menopause or common symptoms alone do not automatically establish eligibility.

How much will women receive while off work?

The employer pays full salary for the first day. From the next day, Social Security pays the benefit. Because the menopause category follows common-contingency sickness rates, the statutory benefit is generally 60% of the regulatory base through day 20 and 75% from day 21.

Does Spain’s menopause leave start immediately?

No. Real Decreto-ley 31/2026 was published on 21 October 2026, but the temporary-incapacity amendments are scheduled to take effect on 1 December 2026. As of 4 November, the decree still required parliamentary validation by the Permanent Deputation.

Does the UK have statutory menopause leave?

No separate statutory menopause-leave right currently exists in Great Britain. Menopause-related issues are instead dealt with through sickness procedures, health-and-safety duties and discrimination law. Employers with 250 or more employees are also moving towards mandatory menopause-support action plans from spring 2027.

Can menopause symptoms count as a disability in the UK?

Potentially. Menopause itself is not automatically a disability, but symptoms may meet the Equality Act definition if they have a substantial and long-term adverse effect on normal day-to-day activities. Where that threshold is met, an employer may have a legal duty to make reasonable adjustments.

Spain’s reform matters partly because of what it does and partly because of what it signals: severe menopause-related ill health is being recognised explicitly as something that can, in individual cases, make a woman genuinely unable to work. At the same time, the evidence argues strongly against framing all menopausal women as less productive or less capable.

For UK women, the immediate takeaway is not that Spain has found a simple model we should copy wholesale. It is that employers and health systems are increasingly being asked to take menopause symptoms seriously, offer individualised support and recognise when symptoms move beyond inconvenience into genuine impairment.

If symptoms are affecting your work, sleep, mood or day-to-day life, speak to your GP or pharmacist for advice that takes account of your individual health and circumstances.